Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Cash (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Change in Cash for 11 consecutive years, with $409303.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 124.78% to $409303.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$342291.0, a 82.59% increase, with the full-year FY2024 number at -$1.9 million, up 67.92% from a year prior.
  • Change in Cash was $409303.0 for Q3 2025 at KORU Medical Systems, up from -$681118.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $966989.0 in Q4 2022 to a low of -$5.2 million in Q1 2023.
  • A 5-year average of -$992171.9 and a median of -$661923.0 in 2024 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 207.62% in 2022; the steepest drop was 1725.12% in 2022.
  • KORU Medical Systems' Change in Cash stood at -$898522.0 in 2021, then soared by 207.62% to $966989.0 in 2022, then decreased by 26.57% to $710062.0 in 2023, then grew by 9.09% to $774637.0 in 2024, then tumbled by 47.16% to $409303.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Change in Cash are $409303.0 (Q3 2025), -$681118.0 (Q2 2025), and -$845113.0 (Q1 2025).